Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505.
about
High dose CHOP: a phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351.A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial.CHOP-like-14 compared to CHOP-like-21 for patients with aggressive lymphoma--a meta-analysis of randomized controlled trials.Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999.Treatment of T-Cell lymphoma.Clinical Trials and Treatment of ATL.Lenograstim: a review of its use in chemotherapy-induced neutropenia, for acceleration of neutrophil recovery following haematopoietic stem cell transplantation and in peripheral blood stem cell mobilization.Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two cases.Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation.
P2860
Q33375173-E51AFED4-8519-4A31-AEE7-B8F667B4C0E1Q35086595-19D02CB2-D4DB-4C8A-9089-CEE4F5424B5CQ35638549-1B703E80-9357-4FFC-B271-6EA0D0DF8578Q36237659-0E53965A-AE8B-4858-920F-2245620844B7Q36270070-4940FBD4-4D58-4F4E-A81F-15F1934035C0Q36422133-C4A0E995-2FBB-4B02-ABC6-CA8EC15F8E64Q37866758-C0E62C5A-FE97-42F4-92A8-9BCBAAAF477DQ38826585-59B6AA46-C766-4740-BBE9-E7ADE6F28A77Q42288107-B7CC07BE-345A-4AAE-8921-B901FDAE78E9
P2860
Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Randomized phase II study of b ...... cal Oncology Group Study 9505.
@ast
Randomized phase II study of b ...... cal Oncology Group Study 9505.
@en
type
label
Randomized phase II study of b ...... cal Oncology Group Study 9505.
@ast
Randomized phase II study of b ...... cal Oncology Group Study 9505.
@en
prefLabel
Randomized phase II study of b ...... cal Oncology Group Study 9505.
@ast
Randomized phase II study of b ...... cal Oncology Group Study 9505.
@en
P2093
P356
P1433
P1476
Randomized phase II study of b ...... cal Oncology Group Study 9505.
@en
P2093
F Mizorogi
M Shimoyama
M Taniwaki
P304
P356
10.1093/ANNONC/MDF287
P577
2002-09-01T00:00:00Z